Registry Of Acute meDical Emergencies in Brazil

NCT ID: NCT02753023

Last Updated: 2018-10-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1650 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-05-31

Study Completion Date

2020-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Critical patients in emergency room are seriously situations that need quickly diagnosis and treatment. Different predictors of prognosis can be related with mortality and morbidity in-hospital and in long-term. In Brazil, this kind of registry is not available. The aim of the study is analysis and report data about critical patients in Emergency Departments over all country, showing demographic, clinical and prognosis data about that in Brazil.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This will be a prospective and multicentric data-bank registry. Initially, all patients with acute coronary syndromes (ACS), acute decompensated heart failure (ADHF), warfarin intoxication, acute pulmonary edema, acute aortic dissection, chest pain, pulmonary embolism and syncope will be included. There will be not exclusion criteria. The inclusion criteria will be followed by definition of each illness described in recent guidelines. Investigators estimated annually over than 500 cases with ACS/chest pain, 300 cases of ADHF, 200 cases of aortic dissection, 200 of pulmonary embolism, 200 cases of warfarin intoxication, 100 cases of syncope and 150 of acute pulmonary edema. Clinical data, electrocardiographic and echocardiographic findings, laboratory results and prognosis will be related. Routine of treatment will be defined by each center. The analysis includes minimum, medium and maximum values. Variables will be adjusted according with each diagnosis and all data will be included using the REDCap digital data entry. Probabilities will be determined by logistic regression and will be considered significate when p \< 0.005. Prospectively, investigators will use the Cox model to calculate associations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Coronary Syndromes Heart Failure Pulmonary Edema Aortic Aneurysm, Familial Thoracic 1 Chest Pain Pulmonary Embolism Syncope

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

acute coronary syndromes

No intervention related

no intervention

Intervention Type OTHER

No intervention related

acute decompensated heart failure

No intervention related

no intervention

Intervention Type OTHER

No intervention related

warfarin intoxication

No intervention related

no intervention

Intervention Type OTHER

No intervention related

acute pulmonary edema

No intervention related

no intervention

Intervention Type OTHER

No intervention related

acute aortic dissection

No intervention related

no intervention

Intervention Type OTHER

No intervention related

chest pain

No intervention related

no intervention

Intervention Type OTHER

No intervention related

pulmonary embolism

No intervention related

no intervention

Intervention Type OTHER

No intervention related

syncope

No intervention related

no intervention

Intervention Type OTHER

No intervention related

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

no intervention

No intervention related

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all patients with:
* acute coronary syndromes (ACS) or,
* acute decompensated heart failure (ADHF) or,
* warfarin intoxication or,
* acute pulmonary edema or,
* acute aortic dissection or,
* chest pain or,
* pulmonary embolism or
* syncope.
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Sao Paulo General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pronto Socorro - Hospital Metropolitano

Vitória, Espírito Santo, Brazil

Site Status RECRUITING

Unidade Coronariana do Hospital Estadual Mario Covas

Santo André, São Paulo, Brazil

Site Status RECRUITING

Hospital Unimed Sorocaba

Sorocaba, São Paulo, Brazil

Site Status RECRUITING

Instituto do Coração - HMFMUSP

São Paulo, , Brazil

Site Status RECRUITING

Pronto Atendimento - Hospital Alemão Oswaldo Cruz

São Paulo, , Brazil

Site Status NOT_YET_RECRUITING

Pronto Socorro - Hospital TotalCor

São Paulo, , Brazil

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Eduardo Al Roque, MD

Role: primary

+ 55 (27) 2104 7056

Caio Fernandes, MD

Role: primary

+55 (11) 98389-5884

Fernando Figuinha, MD

Role: primary

Alexandre Soeiro, MD

Role: primary

5511-2661-5299

Thiago Brito, MD

Role: primary

5511-98213-9363

Pedro Barros e Silva, MD

Role: primary

55 11 993151335

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PSInCor-ROAD-Brazil

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.